baber/WOPTO huggingface dataset:
Patent WO-2022020886-A1 (WO)
Inventor: HUYGENS FLAVIA
IPC: C12Q1/04
Filed: 2021-07-27
Abstract: The present invention relates to a method for detecting replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a sample, said method including the steps of: (a) amplifying a target nucleic acid from a portion of subgenomic mRNA of SARS-CoV-2 from the sample; and (b) detecting the presence or absence of the target nucleic acid amplified in step (a).
Patent AU-2021201449-A1 (AU)
Title: Device, method, and graphical user interface for synchronizing two or more displays
Inventor: SANTAMARIA JUSTIN
IPC: G01C21/36
Filed: 2021-03-05
Abstract: DEVICE, METHOD, AND GRAPHICAL USER INTERFACE FOR 
SYNCHRONIZING TWO OR MORE DISPLAYS 
ABSTRACT 
A device displays a first user interface on a first display, including a plurality of objects 
and corresponding to a second user interface on a second display. While a first object is 
displayed as a selected object in the second user interface, the device: detects a first input 
requesting information about a second object; and in response to detecting the first input, 
displays information about the second object in the first user interface and maintains 
display of the first object as the selected object in the second user interface. After 
displaying the information, the device detects a second input selecting the second object. In 
response to detecting selection of the second input, the device: displays the second object 
as the selected object in the first user interface; and provides, to the second display, 
information that enables the second user interface to display the second object as the 
selected object.
Patent AU-2021201511-A1 (AU)
Title: Pixel arrangement structure, display substrate, display device and mask plate group
Inventor: WANG HONGLI
IPC: H01L27/32
Filed: 2021-03-10
Abstract: C18W2]32.09AU.D] 
ABSTRACT 
A pixel arrangement structure, a display substrate, a display device and a mask plate 
group. The pixel arrangement structure comprises: a plurality of smallest repeating regions 
(100), each of the smallest repeating regions (100) being rectangular and comprising a first 
virtual rectangle (110), a second virtual rectangle (120), a third virtual rectangle (130) and a 
fourth virtual rectangle (140), one first virtual rectangle (110) comprising a first color 
sub-pixel block (111), a second color sub-pixel block (112) and a third color sub-pixel block 
(113); the first virtual rectangles (110) comprise a first side (1101) extending in a first 
direction and a second side (1102) extending in a second direction; the smallest distances of 
the second color sub-pixel blocks (112) and the third color sub-pixel blocks (113) from the 
first sides (1101) are both shorter than the distance between the first color sub-pixel blocks 
(111) and the first sides (1101); a virtual line passing through the first virtual rectangle (110) 
and the fourth virtual rectangle (140) is simultaneously overlapped with the first color 
sub-pixel block (111) of the first virtual rectangle (110) and the first color sub-pixel block 
(111) of the fourth virtual rectangle (140).  
17482081_1 (GH Matters) P111996.AU.1
Patent AU-2021204654-A1 (AU)
Title: Printing formulations and methods
Inventor: COFLER MARIAN
IPC: C09D11/00
Filed: 2021-07-02
Abstract: The present disclosure describes pre-coat formulations, ink formulations, ink systems and 
printing methods for patterning a surface with a desired pattern.
Patent AU-2021219159-A1 (AU)
Title: Anti-CD137 antigen-binding molecule for use in cancer treatment
Inventor: SAKURAI MIKA
IPC: C07K16/46
Filed: 2021-02-10
Abstract: [Problem] The purpose of the present disclosure is to provide: an anti-cancer agent having immune cell activation action, cytotoxic activity, or anti-tumor activity, and yet having little activity against non-tumor tissues such as normal tissues, and also having few side effects; a combination therapy that uses said anti-cancer agent together with other anti-cancer agents; and a pharmaceutical composition for use in the combination therapy. [Solution] Provided are: an anti-cancer agent; a combination therapy using the anti-cancer agent together with other anti-cancer agents; and a pharmaceutical composition for use in the combination therapy. This anti-cancer agent includes an anti-CD137 antigen-binding molecule according to the present disclosure as an active ingredient, where the binding activity of the molecule against CD137 varies depending on a variety of substances (e.g., low molecular compounds) on target tissues. As a result, the anti-cancer agent has immune cell activation action, cytotoxic activity, or anti-tumor activity, and yet has little activity against non-tumor tissues such as normal tissues, and also has few side effects. The anti-cancer agent is expected to be applicable to various types of cancer.
Patent AU-2021221675-A1 (AU)
Title: Encoder controlled laser rangefinder scope tracking system
Inventor: BELLAH BRIAN J
IPC: G01C3/04
Filed: 2021-08-25
Abstract: Provided is a weapon aiming system including a riflescope and a laser 
rangefinder (LRF). The riflescope has at least one turret for adjusting the position of 
an internal reticle aimpoint. At least one encoder senses a relative position change of 
the turret and/or reticle. The LRF includes at least one pair of Risley prisms operable 
to adjustably position a LRF aimpoint to coincide with the aimpoint of the riflescope 
reticle. A motor is associated with each Risley prism. The system is configured such 
that adjusting the aimpoint of the riflescope reticle causes the encoder to send a 
position change signal to a controller programmed to, in response, direct the motor 
to reposition the prisms so that the LRF aimpoint continues to coincide with the 
reticle aimpoint.
1/3 
IJ 
(NJN
Patent AU-2021221911-A1 (AU)
Title: Bed bugs detection device
Inventor: ZIN BENEDICT LOUIS
IPC: G06F7/00
Filed: 2021-08-27
Abstract: System and method embodiments for analyzing a test fluid to detect prior or present 
infestations of bed bugs are described. In an embodiment, the method may include receiving the 
test fluid on a test strip within the detection device. The test strip may include a reaction portion 
and a reagent portion containing an antibody or antigen-binding fragment that is conjugated to a 
colored particle. The test fluid may include bed bug antigen that reacts with the conjugated 
antibody. The detection device may include a first and a second optical sensor for monitoring a 
reaction and a background color intensity, respectively. Upon a predetermined time delay 
elapsing, the detection device determines whether bed bug antigen is present in the test fluid 
using the monitored color intensities and minimum and maximum color intensity thresholds 
associated with bed bugs. Then, the detection device outputs a result using a visual display.
Patent AU-2021225228-A1 (AU)
Title: Human milk products useful in pre- and post-operative care
Inventor: ELSTER SCOTT
IPC: A23C9/152
Filed: 2021-09-03
Abstract: HUMAN MILK PRODUCTS USEFUL IN PRE- AND POST-OPERATIVE CARE 
ABSTRACT 
The present disclosure relates to human milk compositions and methods of making and using 
the same. In particular, the disclosure features methods of using human milk compositions to 
feed subjects before and/or after surgery or medical operations and that are useful in promoting 
recovery.
Patent AU-2021225851-A1 (AU)
Title: Highly active compounds against COVID-19
Inventor: SOMMADOSSI JEAN-PIERRE
IPC: A61P31/14
Filed: 2021-02-24
Abstract: The present invention is the use of purine nucleotide phosphoramidates or pharmaceutically acceptable salts thereof administered in an effective amount for the treatment or prevention of COVID-19, an infection caused by the SARS CoV-2 virus in a host, for example a human, in need thereof.
Patent AU-2021236272-A1 (AU)
Title: Multi-dosage tablet array
Inventor: HELSPER FREEK
IPC: A61J7/00
Filed: 2021-03-09
Abstract: Described is a multi-dosage array of tablets comprising one or more active substances, the tablets being coated and void of tablet portioning means so as to avoid contact of the tablet constituents upon handling by a user for the provision of a plurality of different dosages of the one or more active substances to a plurality of patients of different weight who are in need of the said one or more active substances, the dosage being dependent on the weight of the respective patient, the array of tablets comprising three or more tablet groups, each tablet group consisting of identical tablets having unique identification means and a unique dosage of the one or more active substances, the said tablets differing from tablets of another group of the array in at least the dosage of the said two or more active substances and in the identification means. Further described are a multi-dosage tablet array system, a medicament dosage comprising a plurality of the tablets of the multi-dosage array of tablets, a dosage comprising a plurality of the tablets of the multi-dosage tablet array, a method of providing a dosage of one or more active substances tailored to the body weight of a patient and a method of providing a tailored dosage of one or more active substances to the body weight of a patient.
Patent AU-2021236392-A1 (AU)
Title: Guidewire-management devices and methods thereof
Inventor: HOWELL GLADE H
IPC: A61M25/09
Filed: 2021-03-12
Abstract: Guidewire-management devices and systems thereof are disclosed herein. A guidewire-management device can include a guidewire, a first sleeve, and a second sleeve. The first sleeve can be configured for distally feeding the guidewire out of the gui dewire-management device. The first sleeve can also be configured for proximally feeding the guidewire into the guidewire-management device. The second sleeve can be proximal of the first sleeve in the guidewire-management device. The second sleeve can be configured for feeding the guidewire in concert with the first sleeve. At least a length of the guidewire extending between the first sleeve and the second sleeve can be disposed within a sterile barrier configured to maintain sterility of the guidewire.
Patent AU-2021239972-A1 (AU)
Title: Mounting device for a metal roof
Inventor: HADDOCK DUSTIN M M
IPC: F16B2/06
Filed: 2021-03-15
Abstract: A mounting device or clamp is provided that can be secured to a roof joint without damaging the roof joint. Two roof panels can be joined at a roof joint that extends away from the roof. The clamp has a body with a slot to receive the roof joint. An insert of the clamp is rotatable relative to the body from a first position to a second position. The clamp body can be positioned over the roof joint, and the insert can rotate or pivot from the first position to the second position relative to the body to secure the clamp to the roof joint. In one embodiment, a body of the clamp has a first arm that is concave and the insert has a concave portion to engage the roof joint. Alternatively, in another embodiment, the insert can be connected to the clamp body such that either a first projection or a second projection of the insert faces a roof joint.
Patent AU-2021240139-A1 (AU)
Title: Antibodies that bind human C6 and uses thereof
Inventor: BAAS FRANK
IPC: C07K16/18
Filed: 2021-09-28
Abstract: Isolated monoclonal antibodies that bind to human complement component C6 and related 
antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic methods 
for using the antibodies.
Patent AU-2021254733-A1 (AU)
Title: Cannabinoid synthase variants and methods for their use
Inventor: ZHANG DEQIANG
IPC: C12N9/10
Filed: 2021-04-13
Abstract: The invention relates to a non-natural cannabinoid synthase comprising at least one amino acid variation as compared to a wild type cannabinoid synthase THCAS, comprising three alpha helices (αA, αB and αC) where a disulfide bond is not formed between alpha helix αA and alpha helix αC, wherein the non-natural cannabinoid synthase catalyzes the oxidative cyclization of CBGA into a cannabinoid. The invention further relates to a non-natural THCAS, a non-natural CBDAS, and a non-natural CBCAS. The invention also relates to a nucleic acid, expression construct, and engineered cell for making the non-natural THCAS, CBDAS, and/or CBCAS. Also provided are compositions comprising the non-natural THCAS, CBDAS, and/or CBCAS; isolated non-natural THCAS, CBDAS, and/or CBCAS enzymes; methods of making the isolated enzymes; cell extracts comprising cannabinoids; and methods of making cannabinoids.
Patent AU-2021261020-A1 (AU)
Title: SIRPα deficient macrophages for treating cancer
Inventor: LIU YUAN
IPC: A61P35/00
Filed: 2021-04-23
Abstract: As disclosed herein, SIRPα is integral to immuno-evasion by many different cancer types as well as cancer resistance to therapies, and reducing SIRPα levels on can bolster antigen acquisition, processing, and presentation, decrease TME immunosuppression and thereby promote tumor-specific T cell activation to eliminate tumors and generate an adaptive immune response consisting of memory T cells, circulating antibodies, and plasma cells, all of which may be specific for neo-antigens in the original cancer. Therefore, disclosed are activated SIRPα
Patent AU-2021265844-A1 (AU)
Title: Bulk shrub harvester and related methods
Inventor: PROCK RUSSELL
IPC: A01D34/23
Filed: 2021-04-30
Abstract: The present disclosure provides systems (220;240) and methods (100) of harvesting a shrub from a base of the shrub proximate a ground surface utilizing a shrub harvester (200). The methods (100) include dislodging (102) the shrub from a base of the shrub proximate the ground surface via a shrub dislodging system (220) on shrub harvester (200). The methods (100) also include receiving (104) the shrub via a shrub release system (240) on the shrub harvester (200). The methods further include grasping (106) the shrub via the shrub release system (240) on the shrub harvester (200). The methods also include releasing (108) the shrub via the shrub release system (240), which can include a plurality of catch members (414).
Patent AU-2021273879-A1 (AU)
Title: Computing device
Inventor: ZHANG SHAOHUA
IPC: G06F1/18
Filed: 2021-05-21
Abstract: Disclosed is a computing device, comprising a frame, a computing module, a control module, a power source module and a heat dissipation module, wherein the computing module is arranged in the frame and comprises a power source interface; the power source module comprises a power source connection end, and also comprises a connection box connected to the frame; the power source interface extends from the frame into the connection box; the power source connection end extends into the connection box; and the power source interface and the power source connection end are in connection in the connection box by means of a conducting bar. The computing device of the present invention is provided with a sealable connection box, and a power source and a power source wire of a computing board are connected in the connection box, thus, various power source connection wires are sealed inside the connection box and are prevented from being exposed, such that not only are the safety and aesthetics improved, but also, the connection box is arranged at the top end of a device, so as to facilitate operations. The frame of the present invention is an integrally formed aluminium frame that does not need mounting, and is low in cost and high in strength.
Patent AU-2021297185-A1 (AU)
Title: Novel eutectic solvent
Inventor: TULACHAN BRINDAN
IPC: C30B21/00
Filed: 2021-06-21
Abstract: The present invention discloses a novel eutectic solvent (NES) comprising one or more derivative(s) of methanesulfonic, one or more ammonium salt(s) and one or more hydrogen bond donor(s). The disclosed NES features like low freezing and eutectic points, low viscosity, negligible vapor pressure, non volatility, less water content, high potential window, high thermal stability, high solubility, long shelf life, high recyclability, high biodegradability, high ionic character, air and moisture stability, non-corrosive, non-mutagenic, economical, non-flammable etc., hence having broader applications.
Patent AU-2021309902-A1 (AU)
Title: Treatment of post-operative surgical pain
Inventor: EVANS STEVE
IPC: A61P29/02
Filed: 2021-07-16
Abstract: The present invention relates to a clostridial neurotoxin for use in treating post-operative surgical pain in a patient, said method comprising administering to a patient a clostridial neurotoxin more than 5 days prior to surgery and wherein the clostridial neurotoxin is administered: i) intradermally; or ii) intrathecally. Also provided are corresponding methods of treatment and administration dosages of a clostridial neurotoxin.
Patent AU-2021325387-A1 (AU)
Title: Persistant marking of a target
Inventor: MROZICKI ANTONY
IPC: F41G7/22
Filed: 2021-08-04
Abstract: The present invention relates to a method of marking and identifying a target (110), and in particular, a method of using a Directed Energy Weapon (DEW) to heat a target without damaging it so that the target may be clearly identified by detectors and systems using thermally sensitive imaging.
Patent AU-2021339001-A1 (AU)
Title: Fabrication and thermal shaping of transparent glass
Inventor: RAPP BASTIAN
IPC: C03B19/06
Filed: 2021-09-10
Abstract: The present invention relates to a method of manufacturing a transparent glass article, the manufacturing method comprising the following steps (a) to (f): in step (a), a nanocomposite is provided; in step (b), the nanocomposite is subjected to an external stimulus in order to render it remoldable; in step (c), the nanocomposite is remolded into a predetermined shape in order to obtain a primary structure; in step (d), the primary structure is debound in order to obtain a secondary structure having cavities formed therein; in step (e) which is optional, the cavities of the secondary structure are filled with at least one additive; and in step (f), the secondary structure is sintered to obtain the transparent glass article. The glass particles comprise spherical glass particles having a diameter in the range of 5 nm to 400 nm.
Patent AU-2021348264-A1 (AU)
Title: Methods, systems and devices for monitoring power consumption and generation
Inventor: MEYER BERND
IPC: G01R22/10
Filed: 2021-09-22
Abstract: Embodiments generally relate to a method for allowing power supplied through a cable to be determined. The method comprises receiving magnetic field data, the magnetic field data relating to a magnetic field generated by the cable, receiving reference data, the reference data relating to a current supplied to one or more monitored loads powered through the cable; based on the received magnetic field data and reference data, determining at least one parameter of a function that relates the magnetic field generated by the cable to the power supplied through a cable; and making available the at least one parameter, so that a power supplied by the cable can be determined based on the at least one parameter and a magnetic field value. The one or more monitored loads are a subset of all the loads powered through the cable.
Patent AU-2021357750-A1 (AU)
Title: Aerosol generating article with front end plug
Inventor: CAMPITELLI GENNARO
IPC: A24D1/20
Filed: 2021-10-07
Abstract: An aerosol-generating article comprises an aerosol-generating substrate (12) and a downstream section (14) extending from a downstream end of the aerosol-generating substrate to a downstream end of the aerosol-generating article. The aerosol-generating article further comprises an upstream section (40) extending from an upstream end of the aerosol-generating substrate to an upstream end of the aerosol-generating article. The ratio of the resistance to draw of the upstream section to the resistance to draw of the downstream section is more than 1, and wherein the resistance to draw of the upstream section is no more than 150 mm H
Patent AU-2021365147-A1 (AU)
Title: Pet food compositions
Inventor: JEWELL DENNIS
IPC: A23K50/42
Filed: 2021-10-21
Abstract: Described herein are pet food compositions and methods for using them. Such compositions may comprise betaine and at least two omega-3 polyunsaturated fatty acids; wherein each of the at least two omega-3 polyunsaturated fatty acids comprise an unbranched aliphatic tail having at least 20 carbons. The methods may include feeding the pet an effective amount of the pet food composition.
Patent AU-2021378791-A1 (AU)
Title: Methods to improve site-directed integration frequency
Inventor: BRADLEY JOHN
IPC: C12N15/66
Filed: 2021-11-10
Abstract: The present disclosure relates to compositions and methods for improving site-directed integration frequency in the genome of plant cells.
Patent AU-2021399798-A1 (AU)
Title: Breast shield and breast shield unit
Inventor: FALTUM CARSTEN
IPC: A61M1/06
Filed: 2021-12-13
Abstract: The present invention relates to a breast shield (2) breast shield comprising a housing (4) defining a nipple tunnel (14) and adapted to receive a nipple, wherein the housing (4) is provided with a milk port (26) in communication with the nipple tunnel (14) and a vacuum port (28) in communication with the nipple tunnel (14). For allowing a tender accommodation of the human breast during the expression of milk the invention proposes an insert (6) arranged within the housing and between the nipple tunnel (14) and the milk port (26) and/or the vacuum port (28). The breast shield unit for expressing human breast milk comprises a unit housing (40) with a receptacle (44) adapted to detachably receive a breast shield (2) according to the invention, wherein the receptacle (44) comprises a vacuum interface (46) for generating a negative pressure in the nipple tunnel (14) and a milk interface (48) leading to a milk container (50) adapted to store the expressed human breast milk and wherein in an inserted stage, in which the breast shield is received within the receptacle (44), the vacuum port (28) is in communication with the vacuum interface (46) and the milk port (26) is in communication with the milk interface (48).
Patent WO-2023035039-A1 (WO)
Inventor: THOMAS DALE
IPC: H02K11/33
Filed: 2022-09-12
Abstract: An electric motor has a stator assembly having a stator magnet, a rotor assembly having a rotor magnet magnetically interacting with the stator magnet and a timing circuit which energises an electromagnet to counteract magnetic field interaction between the magnets depending on the rotational position of the rotor assembly. The rotor and stator magnets may be arranged to repel each other. As such, the timing circuit energises the electromagnet as the rotor magnet approaches the stator magnet, thereby diminishing the repulsive force. When the rotor magnet and the stator magnet are substantially adjacent, the electromagnet may be de-energised to thereby no longer inhibit the magnetic interaction, thereby reinstating the repulsive force to repel the rotor magnet away from the stator magnet, thereby inducing rotational force of the rotor assembly.
Patent AU-2022200616-A1 (AU)
Title: Novel peptides and combination of peptides for use in immunotherapy against cll and other cancers
Inventor: MAHR ANDREA
IPC: C07K14/47
Filed: 2022-01-31
Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in 
immunotherapeutic methods. In particular, the present invention relates to the 
immunotherapy of cancer. The present invention furthermore relates to tumor
associated T-cell peptide epitopes, alone or in combination with other tumor
associated peptides that can for example serve as active pharmaceutical ingredients 
of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate 
T cells ex vivo and transfer into patients. Peptides bound to molecules of the major 
histocompatibility complex (MHC), or peptides as such, can also be targets of 
antibodies, soluble T-cell receptors, and other binding molecules.